Subpart B - LABELING REQUIREMENTS FOR PRESCRIPTION DRUGS AND/OR INSULIN
- Section 201.50 - Statement of identity
- Section 201.51 - Declaration of net quantity of contents
- Section 201.55 - Statement of dosage
- Section 201.56 - Requirements on content and format of labeling for human prescription drug and biological products
- Section 201.57 - Specific requirements on content and format of labeling for human prescription drug and biological products described in Section 201.56(b)(1)
- Section 201.58 - Waiver of labeling requirements